Navigation Links
New journal article urges use of animal serum-free media for growing live cells

In the March issue of Trends in Biotechnology, scientists and doctors with the Physicians Committee for Responsible Medicine (PCRM) recommend using only animal serum-free media to grow live cells in the laboratory. At issue is the use of fetal calf serum, which is obtained by puncturing the heart of a fetal calf without anesthesia. Recent breakthroughs permit the growth of human cells in a medium free of animal serum, enabling scientists and researchers to make cell culture safer and more humane.

"Scientists have access to humane and scientifically superior alternatives, so now is the time to completely eliminate the use of fetal calf serum in the laboratory," says Megha Shah Even, M.S., a staff scientist at PCRM and lead author of the paper. Live cells grown in the laboratory are used for many purposes including the manufacture of drugs and diagnostic kits.

Trends in Biotechnology, based in the United Kingdom, invited Mrs. Even to submit a paper after learning that she spearheaded the development of the world's first animal serum-free insulin assay. In addition to humane concerns, the article emphasizes the scientific advantages of serum-free cell culture. Growing cells without animal serum ensures that fewer variables are introduced into experiments, meaning that results are easily reproducible by different laboratories.


'"/>

Source:Physicians Committee for Responsible Medicine


Page: 1

Related biology news :

1. Open Access journals get impressive impact factors
2. Impressive new Impact Factors for BioMed Centrals open-access journals
3. Funding and bureaucracy, not access to journals, are chief obstacles to scientific productivity
4. Public Library of Science to launch new, open access journal on neglected tropical diseases
5. Are journal rankings distorting science?
6. DNA Molecules Used To Assemble Nanoparticles
7. Tiny particles could solve billion-dollar problem
8. Imaging Lymph Nodes with Nanoparticles
9. Taking Aim With Nanoparticle PEBBLEs
10. Probing The Promise And Perils Of Nanoparticles
11. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... "Increase in mobile transactions is driving the ... market is expected to grow from USD 4.03 billion ... a CAGR of 29.3% between 2016 and 2022. The ... demand for smart devices, government initiatives, and increasing penetration ... is expected to grow at a high rate during ...
(Date:12/8/2016)... Dec. 8, 2016  Singulex, Inc., the leader in ... entered into a license and supply agreement with Thermo ... agreement provides Singulex access to Thermo Scientific BRAHMS PCT ... is used to diagnose systemic bacterial infection and ... to aid in assessing the risk of critically ...
(Date:12/7/2016)... , Dec. 7, 2016   Avanade ... successful Formula One teams in history, exploit biometric data ... stop performance and maintain the competitive edge against their ... 2016. Avanade has worked with Williams ... range of biometric data (heart rate, breathing rate, temperature ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... replacement at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica ... technology and host a hands-on workshop for surgeons to experience the simplicity of ...
(Date:1/21/2017)... ... ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New York, USA) announced the ... sales rights for all non-OEM Transonic products in Japan. As partners for more than ... - Transonic JV is a natural next step to advance best practices and further ...
(Date:1/21/2017)... BOULDER, Colo. , Jan. 20, 2017 ... ("Bioptix" or the "Company"), announced that on January 14, ... a plan under which the Company will terminate certain ... subsidiary, Bioptix Diagnostics, Inc.  The Company commenced terminations on ... completed within 30 days.  The Company may pay severance ...
(Date:1/20/2017)... , ... January 20, 2017 , ... The two newest ... treatment options for patients. Vironika, a spin out from The Wistar Institute, and Sanguis, ... lab space at 3624 Market Street. , Vironika is developing a treatment for ...
Breaking Biology Technology: